We monitored tumor growth to explore whether FOXM1 could reverse the effect of PINT87aa overexpression in HCC in vivo and found a larger tumor volume in the FOXM1 overexpression group (Figure 8A). This evidence concerns the gene FOXM1 and hepatocellular carcinoma.